Gsa Capital Partners LLP Neuro Pace Inc Transaction History
Gsa Capital Partners LLP
- $1.35 Billion
- Q4 2024
A detailed history of Gsa Capital Partners LLP transactions in Neuro Pace Inc stock. As of the latest transaction made, Gsa Capital Partners LLP holds 56,384 shares of NPCE stock, worth $739,758. This represents 0.05% of its overall portfolio holdings.
Number of Shares
56,384Holding current value
$739,758% of portfolio
0.05%Shares
1 transactions
Others Institutions Holding NPCE
# of Institutions
55Shares Held
21MCall Options Held
1.3KPut Options Held
100-
Kck Ltd. Tortola, D85.27MShares$69.2 Million78.74% of portfolio
-
Orbimed Advisors LLC San Diego, CA3.41MShares$44.7 Million0.56% of portfolio
-
Morgan Stanley New York, NY2.49MShares$32.7 Million0.0% of portfolio
-
Soleus Capital Management, L.P. Greenwich, CT2.43MShares$31.9 Million1.44% of portfolio
-
Kent Lake Pr LLC Anasco, PR1.25MShares$16.4 Million3.46% of portfolio
About NeuroPace Inc
- Ticker NPCE
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 24,846,900
- Market Cap $326M
- Description
- NeuroPace, Inc. operates as a medical device company in the United States. It develops and sells RNS system, a brain-responsive neuromodulation system for treating medically refractory focal epilepsy by delivering personalized real-time treatment at the seizure source. The company's RNS system also records continuous brain activity data; and ena...